1. Home
  2. GPMT vs ANVS Comparison

GPMT vs ANVS Comparison

Compare GPMT & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Point Mortgage Trust Inc.

GPMT

Granite Point Mortgage Trust Inc.

HOLD

Current Price

$0.94

Market Cap

64.7M

Sector

Real Estate

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$1.30

Market Cap

76.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPMT
ANVS
Founded
2015
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.7M
76.6M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
GPMT
ANVS
Price
$0.94
$1.30
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$3.00
★ $13.50
AVG Volume (30 Days)
298.8K
★ 1.2M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
★ 12.99%
N/A
EPS Growth
★ 73.58
39.39
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$458.85
N/A
Revenue Next Year
$8.63
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$1.04
52 Week High
$3.03
$5.50

Technical Indicators

Market Signals
Indicator
GPMT
ANVS
Relative Strength Index (RSI) 26.29 39.52
Support Level N/A $1.04
Resistance Level $1.56 $1.98
Average True Range (ATR) 0.05 0.08
MACD -0.00 0.02
Stochastic Oscillator 3.49 57.50

Price Performance

Historical Comparison
GPMT
ANVS

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: